Parkinson’s Disease

Category

The Michael J. Fox Foundation for Parkinson’s Research Sponsors Virtual Educational Course to Cultivate Additional Parkinson’s Clinicians

Responding to the urgent need for additional specialists to treat the growing prevalence of people with Parkinson's disease (PD), the International Parkinson and Movement Disorder Society hosted the fifth annual "Pan American Section (MDS-PAS) Movement Disorders...

George Washington University Study Asks: Can Nilotinib be Repurposed from use for Specific Cancer to use for Parkinson’s Disease?

There is tremendous value in identifying new purposes for existing drugs. Recently, Georgetown University Medical Center (GUMC) embarked on a project to do just that for Parkinson’s disease with a cancer drug called nilotinib (Tasigna). They found that the drug in...

Parkinson’s UK & King’s College London Plan Pioneering Clinical Trial to Treat Psychosis in Parkinson’s Patients Using Cannabidiol

Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, has partnered with investigators at King’s College London to invest £1.2 million in a pioneering Phase II clinical trial investigating the use of cannabidiol (CBD)—a compound found...

Pin It on Pinterest